|
Showing the most relevant articles for your search:NASDAQ:KITE | Date | Time | Source | Headline | Symbol | Company | | 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 12/10/2015 | 8:00AM | GlobeNewswire Inc. | Kite Pharma Announces Pricing of Public Offering of Common Stock | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/08/2015 | 5:25PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/08/2015 | 4:20PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/08/2015 | 4:01PM | GlobeNewswire Inc. | Kite Pharma Announces Proposed Public Offering of Common Stock | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/08/2015 | 3:58PM | Edgar (US Regulatory) | Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/07/2015 | 12:00PM | GlobeNewswire Inc. | Kite Pharma Announces Clinical Biomarker Results of Anti-CD19 CAR T Cell Therapy at the 57th American Society of Hematology A... | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/07/2015 | 10:56AM | The Motley Fool | Why Kite Pharma's Shares Took Flight in November | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/07/2015 | 10:03AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/07/2015 | 10:00AM | GlobeNewswire Inc. | Kite Pharma Presents Phase 1 Results From ZUMA-1 at the 57th American Society of Hematology (ASH) Annual Meeting | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/07/2015 | 6:30AM | GlobeNewswire Inc. | Kite Pharma Initiates the ZUMA-4 Study to Support Registration of KTE-C19 for Relapsed or Refractory (r/r) Acute Lymphoblasti... | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/07/2015 | 6:30AM | GlobeNewswire Inc. | Kite Pharma Receives FDA Breakthrough Therapy Designation for KTE-C19 for the Treatment of Refractory, Aggressive Non Hodgkin... | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/05/2015 | 10:04AM | The Motley Fool | Billionaire Doubles Down on 3 Stocks: Time to Buy? | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/03/2015 | 6:54PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/03/2015 | 8:00AM | GlobeNewswire Inc. | Kite Pharma and GE Global Research Announce Strategic Collaboration to Automate Manufacturing of Engineered T Cell Therapies | NASDAQ:KITE | Kite Pharma, Inc. |
| 12/02/2015 | 8:00AM | GlobeNewswire Inc. | Kite Pharma Initiates the ZUMA-3 Study to Support Registration of KTE-C19 for Relapsed or Refractory (r/r) Acute Lymphoblasti... | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/12/2015 | 6:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/12/2015 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/12/2015 | 5:27PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/12/2015 | 4:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/12/2015 | 4:01PM | GlobeNewswire Inc. | Kite Pharma Reports Third Quarter 2015 Financial Results and Provides Business Update | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/10/2015 | 2:27PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/10/2015 | 11:19AM | The Motley Fool | Does Kite Pharma's Stock Still Have Room to Run After Climbing 19% in October? | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/09/2015 | 4:01PM | GlobeNewswire Inc. | Kite Pharma to Host Third Quarter 2015 Financial Results Conference Call and Webcast | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/09/2015 | 8:00AM | GlobeNewswire Inc. | Kite Pharma Initiates Phase 2 Clinical Study of KTE-C19 (ZUMA-2) in Patients With Relapsed or Refractory Mantle Cell Lymphoma... | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/05/2015 | 9:08AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/05/2015 | 9:00AM | GlobeNewswire Inc. | Kite Pharma to Present Four Abstracts, including Safety and Efficacy Data from the KTE-C19 Phase 1 Study in Patients with Ref... | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/04/2015 | 8:00AM | GlobeNewswire Inc. | Kite Pharma to Present at Upcoming Investor Conferences in November 2015 | NASDAQ:KITE | Kite Pharma, Inc. |
| 11/02/2015 | 8:00AM | GlobeNewswire Inc. | Kite Pharma Initiates ZUMA-1 Phase 2 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma (NHL) to Support Registra... | NASDAQ:KITE | Kite Pharma, Inc. |
| 10/28/2015 | 7:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KITE | Kite Pharma, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:KITE |
|